Advertisement
Canada markets open in 1 hour 25 minutes
  • S&P/TSX

    21,516.90
    -94.40 (-0.44%)
     
  • S&P 500

    5,487.03
    +13.80 (+0.25%)
     
  • DOW

    38,834.86
    +56.76 (+0.15%)
     
  • CAD/USD

    0.7295
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    81.73
    +0.16 (+0.20%)
     
  • Bitcoin CAD

    90,585.06
    +1,171.62 (+1.31%)
     
  • CMC Crypto 200

    1,374.54
    -8.13 (-0.59%)
     
  • GOLD FUTURES

    2,352.90
    +6.00 (+0.26%)
     
  • RUSSELL 2000

    2,025.23
    +3.22 (+0.16%)
     
  • 10-Yr Bond

    4.2170
    0.0000 (0.00%)
     
  • NASDAQ futures

    20,022.75
    +103.50 (+0.52%)
     
  • VOLATILITY

    12.59
    +0.11 (+0.88%)
     
  • FTSE

    8,230.96
    +25.85 (+0.32%)
     
  • NIKKEI 225

    38,633.02
    +62.26 (+0.16%)
     
  • CAD/EUR

    0.6803
    +0.0016 (+0.24%)
     

Celldex Therapeutics to Present at Jefferies Healthcare Conference

Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.

HAMPTON, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 6th at 10:00 am ET. A webcast of the presentation will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex website. A replay will be available for 90 days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com